SCHEMBL2910028

SCHEMBL2910028

COC(c1ccccc1)C1(C(C(=O)NC2CCCCC2)C2CCCCC2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
TSHR P16473 2/20 0.45
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
EPHX1 P07099 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 1/20 0.40
C3AR1 Q16581 3/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 1/20 0.38
CCR1 P32246 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915018 0.94 SMN1; SMN2 (0.41) SMN1; SMN2TSHRKMT2AMEN1EPHX1
SCHEMBL2912642 0.92 SMN1; SMN2 (0.43) SMN1; SMN2TSHRKMT2AMEN1EPHX1
SCHEMBL2914472 0.89 MEN1 (0.36) SMN1; SMN2TSHRKMT2AMEN1CYP3A4
SCHEMBL2913162 0.88 KMT2A (0.42) SMN1; SMN2TSHRKMT2AMEN1CYP3A4
SCHEMBL2913040 0.86 TSHR (0.44) SMN1; SMN2TSHRKMT2AMEN1EPHX1
SCHEMBL2306822 0.85 NR1H4 (0.41) SMN1; SMN2TSHRKMT2AMEN1CYP3A4
SCHEMBL2913502 0.85 YAP1 (0.44) SMN1; SMN2TSHRKMT2AMEN1CYP3A4
SCHEMBL2307306 0.85 NR1H4 (0.41) SMN1; SMN2TSHRKMT2AMEN1CYP3A4
SCHEMBL2307838 0.85 NR1H4 (0.41) SMN1; SMN2TSHRCYP3A4CYP2C19RAB9A
SCHEMBL2907044 0.85 TP53 (0.42) SMN1; SMN2TSHRKMT2AMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed